BC
SYRS

Bridgefront Capital’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bridgefront Capital’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,054
Closed -$114K – 954
2020
Q4 		$114K Buy
+1,054
New +$114K 0.04% 561